Manager × security

Paradice Investment Management LLC GMED holdings history

Who else holds this security? →

GLOBUS MEDICAL INC - A · CUSIP 379577208 · CIK 1620275

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Paradice Investment Management LLC reported 493.91K GMED (shares), valued at $39.02M, or 6.23% of its reported non-derivative portfolio. Filed 2026-08-05.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
6.23%
Shares
493.91K
493,906
Reported value
$39.02M
USD

Shares increased 0.54%; reported value decreased 7.81%, and weight changed -1.72 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20266.23%493,906SEC filing ↗Filed Aug 5, 2026
Q1 20267.95%491,265SEC filing ↗Filed May 15, 2026
Q4 20258.98%528,055SEC filing ↗Filed Jan 28, 2026
Q3 20258.52%663,038SEC filing ↗Filed Oct 20, 2025
Q2 20256.58%548,605SEC filing ↗Filed Aug 13, 2025
Q1 20257.11%434,647SEC filing ↗Filed May 12, 2025
Q4 20247.17%436,680SEC filing ↗Filed Jan 31, 2025
Q3 20247.40%594,110SEC filing ↗Filed Nov 7, 2024
Q2 20247.64%630,822SEC filing ↗Filed Aug 1, 2024
Q1 20245.96%641,061SEC filing ↗Filed May 7, 2024
Q4 20235.10%761,836SEC filing ↗Filed Feb 8, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20235.10%761,836$40.60MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 8, 2024
Q1 20245.96%641,061$34.39MShares decreased 15.85%; reported value decreased 15.30%, and weight changed +0.86 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 7, 2024
Q2 20247.64%630,822$43.20MShares decreased 1.60%; reported value increased 25.65%, and weight changed +1.68 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 1, 2024
Q3 20247.40%594,110$42.50MShares decreased 5.82%; reported value decreased 1.63%, and weight changed -0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 7, 2024
Q4 20247.17%436,680$36.12MShares decreased 26.50%; reported value decreased 15.02%, and weight changed -0.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 31, 2025
Q1 20257.11%434,647$31.82MShares decreased 0.47%; reported value decreased 11.91%, and weight changed -0.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 12, 2025
Q2 20256.58%548,605$32.38MShares increased 26.22%; reported value increased 1.77%, and weight changed -0.53 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2025
Q3 20258.52%663,038$37.97MShares increased 20.86%; reported value increased 17.28%, and weight changed +1.94 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 20, 2025
Q4 20258.98%528,055$46.10MShares decreased 20.36%; reported value increased 21.42%, and weight changed +0.46 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 28, 2026
Q1 20267.95%491,265$42.33MShares decreased 6.97%; reported value decreased 8.19%, and weight changed -1.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20266.23%493,906$39.02MShares increased 0.54%; reported value decreased 7.81%, and weight changed -1.72 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 5, 2026
Paradice Investment Management LLC · GLOBUS MEDICAL INC - A

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1620275","quarter":"2026Q2","cusip":"379577208"}

get_institutional_manager_history
{"cik":"1620275","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.